The webinar series, "Moving from Hepatitis Discovery to Elimination: NIH Research Advancing Hepatitis Elimination" will kick off in 2022 with a deep-dive symposium on the latest research related to HCV vaccine development, hosted by the National Institute of Allergy and Infectious Diseases (NIAID). Over two days- March 24th and 25th- eight speakers will discuss results from clinical trials for past candidate vaccines, new findings in HCV immunology and implications for vaccine development, and emerging vaccine platforms, such as mRNA, that could be applied to HCV. Nobel Laureate, Dr. Michael Houghton, will close the symposium with his thoughts on the opportunity of HCV vaccine development within the next decade. Join us by registering below.
